343 related articles for article (PubMed ID: 27193072)
1. Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders.
Manera C; Arena C; Chicca A
Recent Pat CNS Drug Discov; 2016; 10(2):142-156. PubMed ID: 27193072
[TBL] [Abstract][Full Text] [Related]
2. Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.
Chicca A; Arena C; Manera C
Recent Pat CNS Drug Discov; 2016; 10(2):122-141. PubMed ID: 27630088
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
4. Translational potential of allosteric modulators targeting the cannabinoid CB
Lu D; Immadi SS; Wu Z; Kendall DA
Acta Pharmacol Sin; 2019 Mar; 40(3):324-335. PubMed ID: 30333554
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.
Morales P; Hernandez-Folgado L; Goya P; Jagerovic N
Expert Opin Ther Pat; 2016 Jul; 26(7):843-56. PubMed ID: 27215781
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
Tam J
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
Han QW; Yuan YH; Chen NH
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
[TBL] [Abstract][Full Text] [Related]
8. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
9. Modern approaches to the development of synthetic cannabinoid receptor probes.
Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
[TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
11. The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?
Oppong-Damoah A; Gannon BM; Murnane KS
CNS Neurol Disord Drug Targets; 2022; 21(1):3-13. PubMed ID: 33573565
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances on Type-2 Cannabinoid (CB
Gasperi V; Guzzo T; Topai A; Gambacorta N; Ciriaco F; Nicolotti O; Maccarrone M
Curr Med Chem; 2023; 30(12):1420-1457. PubMed ID: 36028971
[TBL] [Abstract][Full Text] [Related]
13. The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.
Brunt TM; Bossong MG
Eur J Neurosci; 2022 Feb; 55(4):909-921. PubMed ID: 32974975
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacology of cannabinoid receptors].
Le Fur G; Rinaldi-Carmona M; Barth F; Alexander J
Bull Acad Natl Med; 2007; 191(4-5):933-8; discussion 938-40. PubMed ID: 18225447
[TBL] [Abstract][Full Text] [Related]
15. Latest progress in the identification of novel synthetic ligands for the cannabinoid CB2 receptor.
Han S; Chen JJ; Chen JZ
Mini Rev Med Chem; 2014 May; 14(5):426-43. PubMed ID: 24766386
[TBL] [Abstract][Full Text] [Related]
16. Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.
Ranieri R; Marasco D; Bifulco M; Malfitano AM
Recent Pat CNS Drug Discov; 2016; 10(2):157-177. PubMed ID: 27184693
[TBL] [Abstract][Full Text] [Related]
17. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
18. Modulating the endocannabinoid system in human health and disease--successes and failures.
Pacher P; Kunos G
FEBS J; 2013 May; 280(9):1918-43. PubMed ID: 23551849
[TBL] [Abstract][Full Text] [Related]
19. CB
Mielnik CA; Lam VM; Ross RA
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110163. PubMed ID: 33152384
[TBL] [Abstract][Full Text] [Related]
20. Recent development of CB2 selective and peripheral CB1/CB2 cannabinoid receptor ligands.
Nevalainen T
Curr Med Chem; 2014; 21(2):187-203. PubMed ID: 24164198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
